ICCC vs UHS · rev $17.5M vs P/E 5.9, rev $9.13B
ImmuCell Corporation (ICCC) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
Latest reported UHS revenue for 2026-06-30 was $9.13B. Net income was $707.1M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
ICCC currently screens at market cap $58.9M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the ICCC and UHS stock pages for the full models.
Not investment advice.